mci 9038 has been researched along with Critical Illness in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Asmis, LM; Bachler, M; Fries, D; Koscielny, J; Lang, T; Nowak, H; Paulus, P; Schewe, JC; von Heymann, C | 1 |
| Baerens, L; Bomberg, H; Enkel, J; Klingele, M; Schäfers, HJ; Speer, T | 1 |
| Coba, VE; Dingman, JS; Peters, MA; Smith, ZR; To, L | 1 |
| Arnold, F; Biever, PM; Kalbhenn, J; Neumann-Haefelin, E; Rieg, S; Tanriver, Y; Walz, G; Westermann, L | 1 |
| Bahlmann, A; Beiderlinden, M; Brezina, T; Görlinger, K; Kemper, J; Kienbaum, P; Schäfer, M; Seidel, H; Treschan, TA; Werner, P | 1 |
| Cao, Z; Han, X; Huang, X; Lin, J; Pu, Z; Ren, K; Sun, W; Tian, L; Wang, Y; Xu, J; Zhang, S; Zhou, W | 1 |
| Toale, KM | 1 |
| Bomberg, H; Fliser, D; Groesdonk, HV; Klingele, M; Lerner-Gräber, A; Poppleton, A; Schäfers, HJ | 1 |
| Bahlmann, A; Beiderlinden, M; Brezina, T; Geib, J; Golla, E; Greinacher, A; Kienbaum, P; Kindgen-Milles, D; Pannen, B; Schaefer, MS; Treschan, TA; Werner, P | 1 |
| Bachler, M; Fries, D; Friesenecker, B; Lorenz, I; Oswald, E; Pedross, F; Schlimp, CJ; Treichl, B | 1 |
| Baumgarten, G; Boehm, O; Graeff, I; Hoeft, A; Kim, SC; Schewe, JC; Tran, N; Wittmann, M | 1 |
| Bek, MJ; Keyl, C; Trenk, D; Wiessner, M; Zimmer, E | 1 |
| Keyl, C; Lehane, C; Trenk, D; Zimmer, E | 1 |
| Böhm, M; Girndt, M; Link, A; Mathes, A; Rensing, H; Selejan, S | 1 |
| Murray, PT | 1 |
| Ernst, NE; Gallagher, EM; Keegan, SP; Mueller, EW; Young, EJ | 1 |
| Doepker, B; Gerlach, AT; Mount, KL; Murphy, CV; Philips, GS; Ryder, LJ | 1 |
| Dolinski, SY; Kincaid, EH; MacGregor, DA; Reichert, MG | 1 |
| Albert, M; Boulanger, I; Grégoire, G; Tardif, M; Williamson, DR | 1 |
| Beiderlinden, M; Görlinger, K; Peters, J; Treschan, TA | 1 |
| Bein, B; Brand, PA; Egberts, JH; Scholz, J; Weiler, N | 1 |
2 review(s) available for mci 9038 and Critical Illness
| Article | Year |
|---|---|
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review.
Topics: Anticoagulants; Arginine; COVID-19; Critical Illness; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Sepsis; Sulfonamides; Thrombocytopenia; Thrombosis; Venous Thromboembolism | 2022 |
Management of anticoagulation in the critically ill patient.
Topics: Anticoagulants; Antithrombins; Arginine; Critical Illness; Heparin; Humans; Pipecolic Acids; Sulfonamides; Venous Thromboembolism | 2013 |
5 trial(s) available for mci 9038 and Critical Illness
| Article | Year |
|---|---|
Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Critical Illness; Double-Blind Method; Drug Monitoring; Female; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombelastography | 2018 |
Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Arginine; Critical Illness; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Recombinant Proteins; Renal Insufficiency; Renal Replacement Therapy; Sulfonamides; Surgical Procedures, Operative; Thrombocytopenia | 2014 |
Argatroban pharmacokinetics and pharmacodynamics in critically ill cardiac surgical patients with suspected heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Cardiac Surgical Procedures; Critical Illness; Female; Half-Life; Heparin; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Prospective Studies; Sulfonamides; Thrombocytopenia | 2016 |
Bleeding risk factors associated with argatroban therapy in the critically ill.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Bilirubin; Critical Illness; Female; Hemoglobins; Hemorrhage; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Retrospective Studies; Risk Factors; Sulfonamides | 2012 |
Argatroban anticoagulation in critically ill patients.
Topics: Anticoagulants; Arginine; Critical Illness; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Multiple Organ Failure; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2007 |
14 other study(ies) available for mci 9038 and Critical Illness
| Article | Year |
|---|---|
Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting.
Topics: Aged; Anticoagulants; Arginine; Cardiac Surgical Procedures; Critical Illness; Elective Surgical Procedures; Erythrocyte Transfusion; Female; Hemoglobins; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Postoperative Hemorrhage; Retrospective Studies; Sulfonamides; Time-to-Treatment | 2020 |
Argatroban dosing requirements in extracorporeal life support and other critically ill populations.
Topics: Anticoagulants; Arginine; Cohort Studies; Critical Illness; Extracorporeal Membrane Oxygenation; Heparin; Humans; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2020 |
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Topics: Acute Kidney Injury; Adult; Aged; Anticoagulants; Arginine; Betacoronavirus; Blood Coagulation; Citric Acid; Comorbidity; Coronavirus Infections; COVID-19; Critical Care; Critical Illness; Equipment Failure; Female; Germany; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Pandemics; Pipecolic Acids; Pneumonia, Viral; Renal Replacement Therapy; Retrospective Studies; SARS-CoV-2; Sulfonamides; Tertiary Care Centers | 2020 |
Thrombosis in the portal venous system caused by hypereosinophilic syndrome: A case report.
Topics: Arginine; Critical Illness; Drug Therapy, Combination; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Heparin; Humans; Hypereosinophilic Syndrome; Male; Pipecolic Acids; Plasma Exchange; Platelet Aggregation Inhibitors; Portal System; Pulmonary Eosinophilia; Sulfonamides; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Urokinase-Type Plasminogen Activator; Venous Thrombosis; Young Adult | 2018 |
Use of argatroban: experiences in continuous renal replacement therapy in critically ill patients after cardiac surgery.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anticoagulants; APACHE; Arginine; Biomarkers; Blood Transfusion; Cardiac Surgical Procedures; Critical Illness; Drug Substitution; Female; Hemoglobins; Heparin; Hospital Mortality; Humans; Male; Middle Aged; Pipecolic Acids; Postoperative Hemorrhage; Renal Dialysis; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome | 2014 |
Efficacy of argatroban in critically ill patients with heparin resistance: a retrospective analysis.
Topics: Anticoagulants; Antithrombin III; Arginine; Critical Illness; Drug Resistance; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides | 2015 |
Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
Topics: Adult; Aged; Anticoagulants; Arginine; Critical Illness; Dose-Response Relationship, Drug; Drug Costs; Female; Germany; Health Care Costs; Hemorrhage; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism | 2015 |
Monitoring anticoagulation with argatroban in critically ill patients: activated partial thromboplastin time versus diluted thrombin time.
Topics: Anticoagulants; Arginine; Critical Illness; Humans; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thrombin Time; Thrombocytopenia | 2016 |
Argatroban for anticoagulation in continuous renal replacement therapy.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Arginine; Critical Illness; Female; Heparin; Humans; Male; Pipecolic Acids; Prospective Studies; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2009 |
"Drug dosing in the intensive care unit: the critically ill are a special population too".
Topics: Anticoagulants; Arginine; Critical Illness; Heparin; Humans; Intensive Care Units; Pipecolic Acids; Renal Insufficiency; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia | 2009 |
Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
Topics: Adult; Aged; Anticoagulants; Arginine; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Female; Heparin; Humans; Male; Middle Aged; Multiple Organ Failure; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2009 |
Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Critical Illness; Drug Overdose; Female; Heparin; Humans; Liver Function Tests; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2003 |
Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.
Topics: Acute Kidney Injury; Aged; Arginine; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heparin; Humans; Infusions, Parenteral; International Normalized Ratio; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Renal Replacement Therapy; Sulfonamides; Thrombocytopenia; Transaminases | 2004 |
Argatroban therapy in patients with hepatic and renal impairment.
Topics: Acute Kidney Injury; Adult; Aged; Anticoagulants; Arginine; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Male; Pipecolic Acids; Postoperative Complications; Sulfonamides | 2008 |